Frontier Field Co., Ltd. announced that it has received funding from Suzuken Co., Ltd., NCB Venture Capital Co., Ltd., Otsuka Pharmaceutical Factory, Inc., SBI Investment Co., Ltd., Yamanashi Chugin Management Consulting Co., Ltd., Investment Arm
July 03, 2023
Share
On July 4, 2023, Frontier Field Co., Ltd. closed the transaction. The company raised an equity round of funding led by new investor Suzuken Co., Ltd. The transaction included participation from new investors NCB Venture Investment Limited Partnership, a fund managed by NCB Venture Capital Co., Ltd, PARAMOUNT BED-SBI Healthcare Fund No. 1 Investment Limited Partnership, a fund managed by SBI Investment Co., Ltd. and Yamanashi Chugin SDGs Fund L.P, a fund managed by Yamanashi Chugin Management Consulting Co., Ltd., Investment Arm.
The shares are issued through third-party allotment method.
Suzuken Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company operates in four business segments. The Pharmaceutical Wholesale segment sells pharmaceuticals, diagnostic drugs, and medical equipment and materials, among others. The Pharmaceutical Manufacturing segment manufactures pharmaceuticals and diagnostic drugs and others. The Insurance Pharmacy segment is engaged in dispensing operations based on prescriptions from medical institutions. The Medical-related Service and Others segment is engaged in the provision of manufacturer support services, such as the transportation of medicines and comprehensive support for the distribution of drugs for rare diseases; the nursing services; the manufacture of physiological examination equipment, such as electrocardiographic monitors and blood pressure monitors; as well as other services, such as the sale of medical books.
Frontier Field Co., Ltd. announced that it has received funding from Suzuken Co., Ltd., NCB Venture Capital Co., Ltd., Otsuka Pharmaceutical Factory, Inc., SBI Investment Co., Ltd., Yamanashi Chugin Management Consulting Co., Ltd., Investment Arm